Kindly MD (NAKA) Stock Price

Kindly MD Price

NYSE·CLOSED
8.95
​
Market closed

Revenue at Kindly MD has contracted by 7.7% per year over the past 4 years to 1.82 M USD. For Kindly MD, the net margin of -2,867.6% is down versus 6.0% a few years ago. The consensus 12-month price target for Kindly MD is 8.00 USD, about 10.6% below where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.

Kindly MD stock price

Access this data via the Eulerpool API

Kindly MD business model & stock analysis

Kindly MD, Inc. provided healthcare services. The company is headquartered in Salt Lake City, Utah and currently employs 23 full-time employees. The company went IPO on 2024-05-31. The firm offers direct health care to patients, integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a fee-for-service basis. The firm offers evaluation and management, including, but not limited to, chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. The firm also collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The firm captures all relevant data points to assist and appropriately treat each individual patient.

Frequently asked questions about Kindly MD

Analysts currently set an average price target of 8.00 USD for the Kindly MD stock (median: 8.00 USD), implying -10.6 % versus the latest price. The consensus is based on 9 analyst ratings.

9 analysts currently rate the Kindly MD stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Kindly MD to generate revenue of 64.10 M USD and earnings per share of -306.14 USD.

Converted at the current exchange rate, the Kindly MD share trades at 7.99 EUR (8.95 USD).

The expected revenue of Kindly MD is 64.10 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Kindly MD is -3.48 B USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Kindly MD is currently -0.03. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Kindly MD stock.

The price-to-sales ratio (P/S) of Kindly MD is currently 1.59. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Kindly MD stock.

The Eulerpool Quality Score for Kindly MD is 1/10.

The ISIN of Kindly MD is US49457M1062. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Kindly MD is NAKA. The ticker symbol is used to trade Kindly MD shares on the stock exchange.

Fair ValueTerminal
8.05 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
55,191.36 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website kindlymd.com
Currency
USD
Initial public offering
May 31, 2024
ISIN
US49457M1062
Cusip
49457M106
Market capitalization
3.94 B USDMid Cap
52-Week Range
PEG
0.03
P/E ratio
P/Ee 2026
-0.03
P/Ee 2027
-0.22
P/Ee 2028
-0.42
P/Se
1.59
EV/EBIT
—
P/B Ratio
7.66
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-7.22 %
Last updated Oct 12, 2026, 11:44 AM

Kindly MD Peer Group